Recall issued for aspiration system by Q’Apel Medical

Apr 24, 2025 - 03:59 PM
fda-alert-recall-compounded-drugs

The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports that included a tip detachment, a vessel rupture and a vasospasm.

Related News Articles

Headline
FDA issues alert for Abiomed heart pump controllers 
The Food and Drug Administration has issued an early alert for all heart pump controllers by Abiomed, which sent a correction notice to all customers with…
Headline
FDA issues most serious recall for certain pacemaker devices by Boston Scientific
The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy…
Headline
FDA identifies recall of catheter kits, Early Alert for sterile labels
The Food and Drug Administration has identified a nationwide recall. Arrow International is recommending dialysis catheter kits containing Merit Medical 16F…
Headline
FDA issues early alert for certain dialysis devices from B. Braun Medical
The Food and Drug Administration has issued an early alert for certain Streamline Airless System Hemodialysis Bloodlines and B3 Low Volume Bloodlines by B.…
Headline
ASPR announces competition for antiviral drug development targeting certain viruses
The Administration for Strategic Preparedness and Response has launched a $100 million competition to support the development of antiviral drug therapies…
Headline
FDA issues most serious recall for certain glucose monitor sensors
The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus…